Characterization of circulating neoantigen-specific T cell responses and public T cell receptors shaping immune memory in Lynch syndrome carriers
4 affiliations
- 1Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 2Institute of Immunology, Medical University of Vienna, Vienna, Austria
- 3Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 4Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Abstract
Lynch syndrome (LS), a common inherited genetic condition predisposing to cancer, provides a unique model to study immune surveillance at the earliest stages of tumorigenesis. A hallmark of LS carcinogenesis is the generation of highly immunogenic neoantigens, yet the transcriptomic states of the T cells that recognize them remain poorly understood. Here, we characterize neoantigen-specific T cells from LS carriers using functional assays, single-cell RNA/T cell receptor (TCR) sequencing, and repertoire integration with existing large datasets. Recurrent neoantigens elicit strong immune responses, with neoantigen-specific T cells mediating cytotoxicity against tumor organoids. Single-cell analysis reveals oligoclonal expansions spanning effector and memory states with enrichment for exhausted subsets among cancer survivors and retention of polyfunctional effectors in cancer-free carriers. Cross-cohort analysis identifies public TCR clonotypes in circulation that overlap with pre-cancer and tumor tissue repertoires. Together, these findings define the architecture of circulating neoantigen-specific immune memory in LS and highlight public TCRs as candidates for immune monitoring and immunoprevention.
Related
- 304 Unselected self-reactivity in neoantigen-specific CD8 T cell clones primes for dysfunction and impairs immunotherapy efficacy
- Selective expansion of neoantigen-specific peripheral blood lymphocytes through antigen-presenting cell-T cell conjugate isolation.
- Effects of Piracetam and Hyperbaric Oxygen on Histopathological and Circulating Biochemical Responses Following Sciatic Nerve Crush Injury in Rats
- Differential sex-dependent responses of circulating steroid hormones and cortical gene expression in a traumatic brain injury model
- A multidimensional proteomic framework of circulating inflammation identifies outcome-specific cardiovascular risk axes in 39,494 UK biobank participants
BibTeX
@article{duzagac2026characterization,
title = {{Characterization of circulating neoantigen-specific T cell responses and public T cell receptors shaping immune memory in Lynch syndrome carriers}},
author = {Fahriye Duzagac and Nan Deng and Jinling Wang and Supriya Nagaraju and Peter Steinberger and Alexandre Reuben and Krishna M. Sinha and Eduardo Vilar},
journal = {Cell Reports Medicine},
year = {2026},
month = sep,
doi = {10.1016/j.xcrm.2026.103057},
url = {https://doi.org/10.1016/j.xcrm.2026.103057},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Characterization of circulating neoantigen-specific T cell responses and public T cell receptors shaping immune memory in Lynch syndrome carriers
AU - Fahriye Duzagac
AU - Nan Deng
AU - Jinling Wang
AU - Supriya Nagaraju
AU - Peter Steinberger
AU - Alexandre Reuben
AU - Krishna M. Sinha
AU - Eduardo Vilar
PY - 2026
DA - 2026/09/18
JO - Cell Reports Medicine
DO - 10.1016/j.xcrm.2026.103057
UR - https://doi.org/10.1016/j.xcrm.2026.103057
AB - Lynch syndrome (LS), a common inherited genetic condition predisposing to cancer, provides a unique model to study immune surveillance at the earliest stages of tumorigenesis. A hallmark of LS carcinogenesis is the generation of highly immunogenic neoantigens, yet the transcriptomic states of the T cells that recognize them remain poorly understood. Here, we characterize neoantigen-specific T cells from LS carriers using functional assays, single-cell RNA/T cell receptor (TCR) sequencing, and repertoire integration with existing large datasets. Recurrent neoantigens elicit strong immune responses, with neoantigen-specific T cells mediating cytotoxicity against tumor organoids. Single-cell analysis reveals oligoclonal expansions spanning effector and memory states with enrichment for exhausted subsets among cancer survivors and retention of polyfunctional effectors in cancer-free carriers. Cross-cohort analysis identifies public TCR clonotypes in circulation that overlap with pre-cancer and tumor tissue repertoires. Together, these findings define the architecture of circulating neoantigen-specific immune memory in LS and highlight public TCRs as candidates for immune monitoring and immunoprevention.
SN - 2666-3791
ER -